Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03899987 |
|
Recruitment Status :
Suspended
(Drug supply issue)
First Posted : April 2, 2019
Last Update Posted : February 6, 2023
|
Sponsor:
Roswell Park Cancer Institute
Collaborator:
AIM ImmunoTech Inc.
Information provided by (Responsible Party):
Roswell Park Cancer Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Suspended |
|---|---|
| Estimated Primary Completion Date : | November 29, 2023 |
| Estimated Study Completion Date : | November 29, 2024 |